Amina Tucak Smajic

Dr. Amina Tucak Smajic

Department of Pharmaceutical Technology, University of Sarajevo, Sarajevo, Bosnia and Herzegovina, Federation of, Bosnia and Herzegovina
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2020 in Micromachines
Verified
Journal Article
Open access
PDF file
Amina Tucak SmajicAmina Tucak Smajic
Amina Tucak Smajic
Merima SirbubaloMerima Sirbubalo
Merima Sirbubalo
LHLamija Hindija
Lamija Hindija
Ognjenka RahicOgnjenka Rahic
Ognjenka Rahic
JHJasmina Hadžiabdić
Jasmina Hadžiabdić
Edina VranićEdina Vranić
Edina Vranić
Although transdermal drug delivery systems (DDS) offer numerous benefits for patients, including the avoidance of both gastric irritation and first-pass metabolism effect, as well as improved patient compliance, only a limited number of active pharmaceutical ingredients (APIs) can be delivered accordingly. Microneedles (MNs) represent one of the most promising concepts for effective transdermal drug delivery that penetrate the protective skin barrier in a minimally invasive and painless manner. The first MNs were produced in the 90s, and since then, this field has been continually evolving. Therefore, different manufacturing methods, not only for MNs but also MN molds, are introduced, which allows for the cost-effective production of MNs for drug and vaccine delivery and even diagnostic/monitoring purposes. The focus of this review is to give a brief overview of MN characteristics, material composition, as well as the production and commercial development of MN-based systems.

22 June 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Merima SirbubaloMerima Sirbubalo
Merima Sirbubalo
Amina Tucak SmajicAmina Tucak Smajic
Amina Tucak Smajic
KMKenan Muhamedagic
Kenan Muhamedagic
LHLamija Hindija
Lamija Hindija
Ognjenka RahicOgnjenka Rahic
Ognjenka Rahic
Edina VranićEdina Vranić
Edina Vranić
Microneedles (MNs) represent the concept of attractive, minimally invasive puncture devices of micron-sized dimensions that penetrate the skin painlessly and thus facilitate the transdermal administration of a wide range of active substances. MNs have been manufactured by a variety of production technologies, from a range of materials, but most of these manufacturing methods are time-consuming and expensive for screening new designs and making any modifications. Additive manufacturing (AM) has become one of the most revolutionary tools in the pharmaceutical field, with its unique ability to manufacture personalized dosage forms and patient-specific medical devices such as MNs. This review aims to summarize various 3D printing technologies that can produce MNs from digital models in a single step, including a survey on their benefits and drawbacks. In addition, this paper highlights current research in the field of 3D printed MN-assisted transdermal drug delivery systems and analyzes parameters affecting the mechanical properties of 3D printed MNs. The current regulatory framework associated with 3D printed MNs as well as different methods for the analysis and evaluation of 3D printed MN properties are outlined.

26 December 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Ognjenka RahicOgnjenka Rahic
Ognjenka Rahic
Amina Tucak SmajicAmina Tucak Smajic
Amina Tucak Smajic
Naida Omerović ĆorovićNaida Omerović Ćorović
Naida Omerović Ćorović
Merima SirbubaloMerima Sirbubalo
Merima Sirbubalo
LHLamija Hindija
Lamija Hindija
Edina VranićEdina Vranić
Edina Vranić
Glaucoma is considered to be one of the biggest health problems in the world. It is the main cause of preventable blindness due to its asymptomatic nature in the early stages on the one hand and patients’ non-adherence on the other. There are several approaches in glaucoma treatment, whereby this has to be individually designed for each patient. The first-line treatment is medication therapy. However, taking into account numerous disadvantages of conventional ophthalmic dosage forms, intensive work has been carried out on the development of novel drug delivery systems for glaucoma. This review aims to provide an overview of formulation solutions and strategies in the development of in situ gel systems, nanosystems, ocular inserts, contact lenses, collagen corneal shields, ocular implants, microneedles, and iontophoretic devices. The results of studies confirming the effectiveness of the aforementioned drug delivery systems were also briefly presented.

11 May 2019
Verified
Book Chapter
Closed access
PDF file
MCMirela Camović
Mirela Camović
ABAmila Biščević
Amila Biščević
IBIman Brčić
Iman Brčić
KBKana Borčak
Kana Borčak
SBSadžida Bušatlić
Sadžida Bušatlić
EVEdina Vranić
Edina Vranić

14 July 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Amina Tucak SmajicAmina Tucak Smajic
Amina Tucak Smajic
IRIvana Ruseska
Ivana Ruseska
ILIlse Letofsky-Papst
Ilse Letofsky-Papst
Edina VranićEdina Vranić
Edina Vranić
Andreas ZimmerAndreas Zimmer
Andreas Zimmer
Although miRNA-27a has been identified as a promising candidate for miRNA mimic therapy of obesity, its application is limited due to enzymatic degradation and low membrane permeation. To overcome these problems, we developed cationic nanostructured lipid carriers (cNLCs) using high-pressure homogenization and used them as non-viral carriers for the anti-adipogenic miRNA-27a. Cargo-free octadecylamine-containing NLCs and miRNA/cNLC complexes were characterized regarding particle size, size distributions, zeta potential, pH values, particle topography and morphology, and entrapment efficacy. Furthermore, the cytotoxicity and cellular uptake of the miRNA/cNLC complex in the 3T3-L1 cell line were investigated. The investigation of the biological effect of miRNA-27a on adipocyte development and an estimation of the accumulated Oil-Red-O (ORO) dye in lipid droplets in mature adipocytes were assessed with light microscopy and absorbance measurements. The obtained data show that cNLCs represent a suitable DDS for miRNAs, as miRNA/cNLC particles are rapidly formed through non-covalent complexation due to electrostatic interactions between both components. The miRNA-27a/cNLC complex induced an anti-adipogenic effect on miRNA-27a by reducing lipid droplet accumulation in mature adipocytes, indicating that this approach might be used as a new therapeutic strategy for miRNA mimic replacement therapies in the prevention or treatment of obesity and obesity-related disorders.

18 March 2021 in J
Verified
Journal Article
Open access
PDF file
Ognjenka RahicOgnjenka Rahic
Ognjenka Rahic
Amina Tucak SmajicAmina Tucak Smajic
Amina Tucak Smajic
Merima SirbubaloMerima Sirbubalo
Merima Sirbubalo
LHLamija Hindija
Lamija Hindija
JHJasmina Hadžiabdić
Jasmina Hadžiabdić
Although homeostasis is a commonly accepted concept, there is incontrovertible evidence that biological processes and functions are variable and that variability occurs in cycles. In order to explain and understand dysregulation, which has not been embraced by homeostatic principles, the allostatic model has emerged as the first serious challenge to homeostasis, going beyond its homeostatic roots. Circadian rhythm is the predominant variation in the body, and it is a pattern according to which many physiological and pathological events occur. As there is strong experimental and clinical evidence that blood pressure fluctuations undergo circadian rhythm, there is equally strong evidence that targeted time therapy for hypertension provides a better outcome of the disease. The research has gone even further throughout the development and approval process for the use of pulsatile drug release systems, which can be considered as an option for an even more convenient dosage regimen of the medicines needed.